Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Elan Corporation

http://www.elan.com

Latest From Elan Corporation

The Long Learning Curve For Artificially Intelligent Drug Manufacturing Begins Now

Drugmakers quickly adopt low-impact AI/ML models in quest to eventually automate manufacturing processes. Already, they are learning a lot about how these models can support their operations. One finding: innovative change management approaches may be required to unlock their full potential.

Artificial Intelligence Manufacturing

Preterm Birth Patients Sought By US FDA As Meeting On Treatment Development Looms

With the only FDA-approved treatment off the market, the FDA is looking for ideas for development of new preterm birth treatments.

Women's Health Research & Development

US FDA’s Sentinel System Strives To Stay Ahead Of Its Own Success

The sprawling safety surveillance system is propelling advances in informatics and advanced analytics, but the agency is delaying next contracting cycle to digest its experience.

Drug Safety Post Market Regulation & Studies

More Than Just Humira: US Biosimilars Enjoy An Eventful 2023

The launch of competition to Humira was the main event for US biosimilars this year – but a number of other key developments also took place in 2023, including settlements on Stelara that set up a series of launches in 2025, as well as first approvals for ustekinumab, natalizumab and tocilizumab biosimilars.

Biosimilars Business Strategies
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Other Names / Subsidiaries
    • Onclave Therapeutics Limited
UsernamePublicRestriction

Register